Criteria for mutation analysis in MEN 1-suspected patients: MEN 1 case-finding

European Journal of Clinical Investigation

Volumn 30, Issue 6, 2000, Pages 487-492

  Roijers, J F M ^b   De Wit, M J ^b   Van Der Luijt, R B ^b   Ploos Van Amstel, H K ^b   Hoppener J W M ^b   Lips, C J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Case finding; Germ line mutations; MEN 1 gene; Multiple endocrine neoplasia type 1; Multiple endocrine neoplasia type 1 suspected patients; Mutation detection rate

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FOLLOW UP; GENE MUTATION; GENETIC COUNSELING; GERM LINE; HETEROZYGOTE DETECTION; HUMAN; HUMAN CELL; MULTIPLE ENDOCRINE NEOPLASIA; ONSET AGE; PRIORITY JOURNAL;

ADULT; AGED; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; FAMILY HEALTH; FEMALE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; INTRONS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; RNA, NEOPLASM;

EID: 0034091091     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00664.x     Document Type: Article

References (24)

1. 1 Larsson C, Nordenskjöld M. Multiple Endocrine Neoplasia. Cancer Surv 1990;9:703-23.
2. 2 Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M. Multiple Endocrine Neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988;332:85-7.
3. 3 The European Consortium on MEN 1. Definition of the minimal MEN 1 candidate area based on a 5 Mb integrated map of proximal 11q13. Genonrics 1996;37:354-65.
4. 4 Chandrasekharappa SC, Guru SC, Manickham P, Olufemi S, Collins FS, Emmert-Buck MR et al. Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1. Science 1997;276:404-7.
5. 5 The European Consortium on MEN 1. Identification of the Multiple Endocrine Neoplasia Type 1 (MEN 1) gene. Hum Mol Genet 1997;6:1177-83.
6. 6 Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins ES et al. Menin, the product of the MEN 1 gene, is a nuclear protein. Proc Natl Acad Sci USA 1999;95:1630-4.
7. 7 Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY et al. Menin Interacts with the API Transcription Factor JunD and Represses JunD-Activated Transcription. Cell 1999;96:143-52.
8. 8 Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN 1). Q J Med 1996;89:653-69.
9. 9 Marx SJ, Agarwal SK, Kester MB, Heppner C, Kim YS, Emmert-Buck MR. Germline and somatic mutation of the gene for multiple endocrine Neoplasia Type 1 (MEN 1). J Intern Med 1998;243:447-53.
10. 10 Bassett JHD, Forbes SA, Pannett AA, Lloyd SE, Christie PT, Wooding C et al. Characterization of Mutations in Patients with Multiple Endocrine Neoplasia Type 1. Am J Hum Genet 1998;62:232-44.
11. 11 Giraud S, Zhang CX, Serova-Sinilnikova O, Wautot V, Salandre J, Buisson N et al. Germ-Line Mutation Analysis in Patients with Multiple Endocrine Neoplasia Type 1 and Related Disorders. Am J Hum Genet 1998;63:455-67.
12. 12 Teh BT, Kytölä S, Farnebo F, Bergman L, Wong FK, Weber G et al. Mutation analysis of the MEN 1 gene in Multiple Endocrine Neoplasia Type 1, Familial Acromegaly and Familial isolated Hyperparathyroidism. J Clin Endocrinol Metab 1998;83:2621-6.
13. 13 Miedlich S, Ackermann F, Krohn K, Lamesch P, Müller A, Paschke R. Somatic MEN1-mutations and clonality in parathyroid tumors of patients with primary and refractory secondary hyperparathyroidism. Seventh International workshop on Multiple Endocrine Neoplasia, Gubbio-Italy. Abstract book. Florence, Italy: Brandi ML; 1999.p.212.
14. 14 Spada A, Corbetta S, Peracchi M. MEN 1 Pituitary tumors. Seventh International workshop on Multiple Endocrine Neoplasia, Gubbio-Italy. Abstract book: Florence, Italy: Brandi ML; 1999.p.63-5.
15. 15 Cupisti K, Höppner W, Dotzenrath C, Simon D, Berndt I, Röher HD et al. Is a MEN 1 screening useful in sporadic insulinomas? Seventh International workshop on Multiple Endocrine Neoplasia, Gubbio-Italy. Abstract book: Florence, Italy: Brandi ML; 1999.p.216.
16. 16 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988;16:3.
17. 17 Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmert-Buck MR, Skarulis MC et al. Germline mutations of the MEN1 gene in Familial Multiple Endocrine Neoplasia Type 1 and related states. Hum Mol Genet 1997;6:1169-75.
18. 18 Teh BT, Zedenius J, Kytölä S, Skogseid B, Trotter J, Choplin H et al. Thymic Carcinoids in Multiple Endocrine Neoplasia Type 1. Ann Surg 1998;228:99-105.
19. 19 Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Rester MB, Lubensky IA et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 1997;6:2285-90.
20. 20 Chanson P, Cadiot G, Murat A. Management of patients and subjects at risk for multiple endocrine neoplasia type 1 : MEN 1. GENEM 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples de type1. Horm Res 1997;47(4-6):211-20.
21. 21 Roscigno RF, Weiner M, Garcia-Blanco MA. A Mutational Analysis of the Polypyrimidine Tracts of Introns. J Biol Chem 1993;268:11222-9.
22. 22 Rishi M, Tsukada T, Shimizu S, Futami H, Ito Y, Kanbe M et al. A large germline deletion of the MEN1 gene in a family with Multiple Endocrine Neoplasia Type 1. Jpn J Cancer Res 1998;89:1-5.
23. 23 Eng C, Clayton D, Schuffencker I, Lenoir G, Cote G, Gagel RF et al. The relationship between specific RET protooncogene mutations and disease phenotype in Multiple Endocrine Neoplasia Type 2: International RET Mutation Consortium analysis. J Am Med Assoc 1996;276:1575-9.
24. 24 Lips CJM, Höppener JWM. Molecular genetics and clinical implications of medullary thyroid carcinoma and mutations of the RET proto-oncogene. Curr Opinion Endocrinol Diabetes 1996;3:439-48.